Is XAIR or ICU more profitable?

Beyond Air has a net margin of -435.71% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -435.71% -440.26% -98.50% SeaStar Medical -795.51% -162.75% -109.89%

Do analysts rate XAIR or TMDIF?

Beyond Air presently has a consensus target price of $105.00, suggesting a potential upside of 2,824.79%. Given Beyond Air's stronger consensus rating and higher probable upside, research analysts plainly believe Beyond Air is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beyond Air 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings & valuation, XAIR or TMDIF?

Titan Medical has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Beyond Air $7.68M 0.45 -$33.25M -$68.40 N/A Titan Medical $17.63M 0.85 $6.95M $0.05 2.64

Is XAIR or TMDIF more profitable?

Titan Medical has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Titan Medical's return on equity of -82.31% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -435.71% -440.26% -98.50% Titan Medical N/A -82.31% -51.47%

Which has stronger earnings and valuation, IRIX or XAIR?

IRIDEX has higher revenue and earnings than Beyond Air. IRIDEX is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.23 -$4.44M -$0.20 N/A Beyond Air $7.68M 0.45 -$33.25M -$68.40 N/A

Is IRIX or XAIR more profitable?

IRIDEX has a net margin of -6.88% compared to Beyond Air's net margin of -435.71%. IRIDEX's return on equity of 0.00% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.88% N/A -12.55% Beyond Air -435.71% -440.26% -98.50%

Is ADGM or XAIR more profitable?

Adagio Medical has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Beyond Air's return on equity of -440.26% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Adagio Medical N/A -661.85% -73.35% Beyond Air -435.71% -440.26% -98.50%

Is XAIR or HSCS more profitable?

HeartSciences has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. HeartSciences' return on equity of -358.60% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -435.71% -440.26% -98.50% HeartSciences N/A -358.60% -144.82%

Does the media favor XAIR or HSCS?

In the previous week, Beyond Air had 5 more articles in the media than HeartSciences. MarketBeat recorded 6 mentions for Beyond Air and 1 mentions for HeartSciences. Beyond Air's average media sentiment score of 0.14 beat HeartSciences' score of 0.00 indicating that Beyond Air is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beyond Air 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Beyond Air (XAIR) Competitors

$3.59 -0.03 (-0.83%)

As of 09/3/2026 04:00 PM Eastern

Compare

XAIR vs. ICU, TMDIF, IRIX, ADGM, and HSCS

Should you buy Beyond Air stock or one of its competitors? Beyond Air's main competitors and comparable companies include SeaStar Medical (ICU), Titan Medical (TMDIF), IRIDEX (IRIX), Adagio Medical (ADGM), and HeartSciences (HSCS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Beyond Air compare to SeaStar Medical?

Beyond Air (NASDAQ:XAIR) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

Beyond Air presently has a consensus price target of $105.00, indicating a potential upside of 2,824.79%. SeaStar Medical has a consensus price target of $8.00, indicating a potential upside of 174.91%. Given Beyond Air's stronger consensus rating and higher possible upside, research analysts clearly believe Beyond Air is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Beyond Air had 6 more articles in the media than SeaStar Medical. MarketBeat recorded 6 mentions for Beyond Air and 0 mentions for SeaStar Medical. Beyond Air's average media sentiment score of 0.14 beat SeaStar Medical's score of 0.00 indicating that Beyond Air is being referred to more favorably in the media.

Company	Overall Sentiment
Beyond Air	Neutral
SeaStar Medical	Neutral

Beyond Air has a net margin of -435.71% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-435.71%	-440.26%	-98.50%
SeaStar Medical	-795.51%	-162.75%	-109.89%

Beyond Air has a beta of 0.13, meaning that its stock price is 87% less volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, meaning that its stock price is 205% less volatile than the broader market.

SeaStar Medical has lower revenue, but higher earnings than Beyond Air. SeaStar Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.45	-$33.25M	-$68.40	N/A
SeaStar Medical	$1.23M	10.43	-$12.15M	-$3.91	N/A

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 10.0% of Beyond Air shares are held by company insiders. Comparatively, 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Beyond Air beats SeaStar Medical on 12 of the 16 factors compared between the two stocks.

How does Beyond Air compare to Titan Medical?

Beyond Air (NASDAQ:XAIR) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

In the previous week, Beyond Air had 6 more articles in the media than Titan Medical. MarketBeat recorded 6 mentions for Beyond Air and 0 mentions for Titan Medical. Beyond Air's average media sentiment score of 0.14 beat Titan Medical's score of 0.00 indicating that Beyond Air is being referred to more favorably in the media.

Company	Overall Sentiment
Beyond Air	Neutral
Titan Medical	Neutral

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Titan Medical has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.45	-$33.25M	-$68.40	N/A
Titan Medical	$17.63M	0.85	$6.95M	$0.05	2.64

Titan Medical has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Titan Medical's return on equity of -82.31% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-435.71%	-440.26%	-98.50%
Titan Medical	N/A	-82.31%	-51.47%

Beyond Air has a beta of 0.13, indicating that its share price is 87% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Beyond Air presently has a consensus target price of $105.00, suggesting a potential upside of 2,824.79%. Given Beyond Air's stronger consensus rating and higher probable upside, research analysts plainly believe Beyond Air is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Beyond Air and Titan Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Beyond Air compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and Beyond Air (NASDAQ:XAIR) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings.

In the previous week, Beyond Air had 6 more articles in the media than IRIDEX. MarketBeat recorded 6 mentions for Beyond Air and 0 mentions for IRIDEX. Beyond Air's average media sentiment score of 0.14 beat IRIDEX's score of 0.00 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Overall Sentiment
IRIDEX	Neutral
Beyond Air	Neutral

IRIDEX presently has a consensus target price of $3.00, suggesting a potential upside of 328.14%. Beyond Air has a consensus target price of $105.00, suggesting a potential upside of 2,824.79%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts plainly believe Beyond Air is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

IRIDEX has higher revenue and earnings than Beyond Air. IRIDEX is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.23	-$4.44M	-$0.20	N/A
Beyond Air	$7.68M	0.45	-$33.25M	-$68.40	N/A

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 8.6% of IRIDEX shares are held by insiders. Comparatively, 10.0% of Beyond Air shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

IRIDEX has a net margin of -6.88% compared to Beyond Air's net margin of -435.71%. IRIDEX's return on equity of 0.00% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.88%	N/A	-12.55%
Beyond Air	-435.71%	-440.26%	-98.50%

IRIDEX has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.13, suggesting that its stock price is 87% less volatile than the broader market.

Summary

Beyond Air beats IRIDEX on 9 of the 16 factors compared between the two stocks.

How does Beyond Air compare to Adagio Medical?

Adagio Medical (NASDAQ:ADGM) and Beyond Air (NASDAQ:XAIR) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment.

Adagio Medical has higher earnings, but lower revenue than Beyond Air. Adagio Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600K	20.01	-$25.08M	-$1.48	N/A
Beyond Air	$7.68M	0.45	-$33.25M	-$68.40	N/A

Adagio Medical has a beta of -0.09, meaning that its stock price is 109% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.13, meaning that its stock price is 87% less volatile than the broader market.

Adagio Medical has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Beyond Air's return on equity of -440.26% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
Beyond Air	-435.71%	-440.26%	-98.50%

Adagio Medical presently has a consensus price target of $3.50, indicating a potential upside of 547.31%. Beyond Air has a consensus price target of $105.00, indicating a potential upside of 2,824.79%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Adagio Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Beyond Air had 6 more articles in the media than Adagio Medical. MarketBeat recorded 6 mentions for Beyond Air and 0 mentions for Adagio Medical. Beyond Air's average media sentiment score of 0.14 beat Adagio Medical's score of 0.00 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Overall Sentiment
Adagio Medical	Neutral
Beyond Air	Neutral

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 7.8% of Adagio Medical shares are held by company insiders. Comparatively, 10.0% of Beyond Air shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Beyond Air beats Adagio Medical on 10 of the 16 factors compared between the two stocks.

How does Beyond Air compare to HeartSciences?

Beyond Air (NASDAQ:XAIR) and HeartSciences (NASDAQ:HSCS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.

In the previous week, Beyond Air had 5 more articles in the media than HeartSciences. MarketBeat recorded 6 mentions for Beyond Air and 1 mentions for HeartSciences. Beyond Air's average media sentiment score of 0.14 beat HeartSciences' score of 0.00 indicating that Beyond Air is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beyond Air	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HeartSciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

HeartSciences has lower revenue, but higher earnings than Beyond Air. HeartSciences is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.68M	0.45	-$33.25M	-$68.40	N/A
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A

Beyond Air has a beta of 0.13, suggesting that its share price is 87% less volatile than the broader market. Comparatively, HeartSciences has a beta of 1.85, suggesting that its share price is 85% more volatile than the broader market.

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by insiders. Comparatively, 4.9% of HeartSciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

HeartSciences has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. HeartSciences' return on equity of -358.60% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-435.71%	-440.26%	-98.50%
HeartSciences	N/A	-358.60%	-144.82%

Beyond Air presently has a consensus price target of $105.00, indicating a potential upside of 2,824.79%. HeartSciences has a consensus price target of $8.00, indicating a potential upside of 138.10%. Given Beyond Air's stronger consensus rating and higher probable upside, equities research analysts plainly believe Beyond Air is more favorable than HeartSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Beyond Air beats HeartSciences on 10 of the 15 factors compared between the two stocks.

Get Beyond Air News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XAIR vs. The Competition

Export

Metric	Beyond Air	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.47M	$5.81B	$7.26B	$12.73B
Dividend Yield	N/A	1.76%	2.53%	8.86%
P/E Ratio	-0.05	25.93	273.28	25.38
Price / Sales	0.45	73.29	613.48	92.60
Price / Cash	N/A	33.14	77.82	52.26
Price / Book	1.21	6.04	12.89	6.14
Net Income	-$33.25M	$150.03M	$3.47B	$349.01M
7 Day Performance	-19.87%	-1.30%	0.61%	-0.27%
1 Month Performance	-41.91%	1.29%	5.73%	0.68%
1 Year Performance	-91.73%	9.89%	25.37%	14.84%

Beyond Air Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XAIR Beyond Air	3.2972 of 5 stars	$3.59 -0.8%	$105.00 +2,824.8%	-92.2%	$3.47M	$7.68M	N/A	70	Analyst Forecast
ICU SeaStar Medical	2.6743 of 5 stars	$3.23 +1.4%	$8.00 +148.1%	-66.3%	$14.22M	$1.23M	N/A	2
TMDIF Titan Medical	N/A	$0.12 -16.8%	N/A	-60.8%	$13.49M	$17.63M	N/A	50
IRIX IRIDEX	1.6289 of 5 stars	$0.74 -1.5%	$3.00 +308.2%	-49.4%	$12.91M	$52.67M	N/A	120
ADGM Adagio Medical	1.7297 of 5 stars	$0.54 -1.5%	$3.50 +545.8%	-66.9%	$11.95M	$600K	N/A	87

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XAIR) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beyond Air (XAIR) Competitors

XAIR vs. ICU, TMDIF, IRIX, ADGM, and HSCS

How does Beyond Air compare to SeaStar Medical?

Summary

How does Beyond Air compare to Titan Medical?

Summary

How does Beyond Air compare to IRIDEX?

Summary

How does Beyond Air compare to Adagio Medical?

Summary

How does Beyond Air compare to HeartSciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beyond Air (XAIR) Competitors

XAIR vs. ICU, TMDIF, IRIX, ADGM, and HSCS

How does Beyond Air compare to SeaStar Medical?

Do analysts recommend XAIR or ICU?

Does the media refer more to XAIR or ICU?

Is XAIR or ICU more profitable?

Which has more volatility and risk, XAIR or ICU?

Which has stronger earnings & valuation, XAIR or ICU?

Do institutionals & insiders hold more shares of XAIR or ICU?

Summary

How does Beyond Air compare to Titan Medical?

Does the media refer more to XAIR or TMDIF?

Do insiders and institutionals hold more shares of XAIR or TMDIF?

Which has better earnings & valuation, XAIR or TMDIF?

Is XAIR or TMDIF more profitable?

Which has more risk & volatility, XAIR or TMDIF?

Do analysts rate XAIR or TMDIF?

Summary

How does Beyond Air compare to IRIDEX?

Does the media refer more to IRIX or XAIR?

Do analysts rate IRIX or XAIR?

Which has stronger earnings and valuation, IRIX or XAIR?

Do institutionals and insiders hold more shares of IRIX or XAIR?

Is IRIX or XAIR more profitable?

Which has more risk and volatility, IRIX or XAIR?

Summary

How does Beyond Air compare to Adagio Medical?

Which has better valuation and earnings, ADGM or XAIR?

Which has more volatility and risk, ADGM or XAIR?

Is ADGM or XAIR more profitable?

Do analysts prefer ADGM or XAIR?

Does the media refer more to ADGM or XAIR?

Do insiders & institutionals believe in ADGM or XAIR?

Summary

How does Beyond Air compare to HeartSciences?

Does the media favor XAIR or HSCS?

Which has higher earnings and valuation, XAIR or HSCS?

Which has more volatility and risk, XAIR or HSCS?

Do institutionals and insiders hold more shares of XAIR or HSCS?

Is XAIR or HSCS more profitable?

Do analysts rate XAIR or HSCS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools